Surprising they when the trials are doing well. I wouldn't be surprised if they sold because of management/fed up seeing Dan's financial self dealing that is dilliutive to and out of line with shareholder interests. I would love to see Adage and Broadfin put pressure on Dan to stop the excessive exec bonus comp until he first delivers a shareholder ROI.